Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16337480 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Condition: Obstructive Sleep Apnea Syndrome
Interventions: Drug: Atorvastatin treatment;   Other: CPAP device;   Other: sham CPAP treatment

Indicates status has not been verified in more than two years